Hepion Pharmaceuticals
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Employees
- 22
- Market Cap
- $4.5M
- Website
- http://www.hepionpharma.com
- Introduction
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2...
Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Hepion Pharmaceuticals, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05737433
- Locations
- ๐ฌ๐ง
Quotient Sciences, Nottingham, United Kingdom
A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3
- Conditions
- Interventions
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Hepion Pharmaceuticals, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05461105
- Locations
- ๐บ๐ธ
Arizona Liver Health-Tucson, Tucson, Arizona, United States
๐บ๐ธSynergy Healthcare, LLC, Bradenton, Florida, United States
๐บ๐ธCovenant Metabolic Specialists-Fort Myers, Fort Myers, Florida, United States
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Hepion Pharmaceuticals, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05402371
- Locations
- ๐บ๐ธ
Entrust Clinical Research, Miami, Florida, United States
๐บ๐ธUnited Reseach Group, Miami, Florida, United States
๐บ๐ธSynergy Healthcare, LLC, Bradenton, Florida, United States
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Hepion Pharmaceuticals, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT04480710
- Locations
- ๐บ๐ธ
La Salud Research, Inc., Miami, Florida, United States
๐บ๐ธGastrointestinal Specialists of Georgia, Marietta, Georgia, United States
๐บ๐ธConquest Clinical Research, Orange, California, United States
A Study in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2021-12-01
- Lead Sponsor
- Hepion Pharmaceuticals, Inc.
- Target Recruit Count
- 92
- Registration Number
- NCT03596697
- Locations
- ๐บ๐ธ
Pinnacle Clinical Research, San Antonio, Texas, United States
๐บ๐ธCelerion, Inc, Lincoln, Nebraska, United States